These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31836602)

  • 21. Incidence of cervical cytological abnormalities following a negative smear result in an opportunistic screening scenario: A cohort study.
    Pinho-França JR; Costa Chein MBD; Thuler LCS
    Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():103-108. PubMed ID: 31580961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of screening with conventional Pap smear in Austria - a longitudinal evaluation.
    Rásky É; Regitnig P; Schenouda M; Burkert N; Freidl W
    BMC Public Health; 2013 Oct; 13():998. PubMed ID: 24152300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
    Martingano D; Renson A; Martingano AJ; Martingano FX
    J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cervical cancer screening in the State of Maranhão, Brazil].
    Silva DS; Silva AM; Brito LM; Gomes SR; Nascimento Mdo D; Chein MB
    Cien Saude Colet; 2014 Apr; 19(4):1163-70. PubMed ID: 24820599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of uterine cervical cancer in pregnancy: A cross-sectional study.
    Vasques RB; Carramenha LL; Basílio I; Leão MEB; Carvalho GPSL; Amaral RMC; Rezende-Filho J; Guerra Neto NGM; Furtado YL
    Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():35-39. PubMed ID: 31927408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
    J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
    Misra JS; Srivastava AN; Gupta HP
    Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
    Al Rifai R; Nakamura K
    Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.
    Nayir T; Okyay RA; Nazlican E; Yesilyurt H; Akbaba M; Ilhan B; Kemik A
    Asian Pac J Cancer Prev; 2015; 16(16):6909-12. PubMed ID: 26514466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears.
    Matheus ER; Zonta MA; Discacciati MG; Paruci P; Velame F; Cardeal LB; Barros SB; Pignatari AC; Maria-Engler SS
    Diagn Cytopathol; 2014 Oct; 42(10):827-33. PubMed ID: 24578283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case.
    Chocontá-Piraquive LA; Alvis-Guzman N; De la Hoz-Restrepo F
    BMC Health Serv Res; 2010 Sep; 10():270. PubMed ID: 20846446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
    Dhanasekaran K; Verma C; Kumar V; Hariprasad R; Gupta R; Gupta S; Mehrotra R
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1265-1269. PubMed ID: 31030504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
    Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
    Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
    Tavasoli SM; Kane E; Kupets R
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
    Shlay JC; McGill WL; Masloboeva HA; Douglas JM
    Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age Specific Cytological Abnormalities in Women Screened for Cervical Cancer in the Emirate of Abu Dhabi.
    Al Zaabi M; Al Muqbali S; Al Sayadi T; Al Ameeri S; Coetsee K; Balayah Z; Ortashi O
    Asian Pac J Cancer Prev; 2015; 16(15):6375-9. PubMed ID: 26434845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of high risk human papillomavirus infection with different cervical cytological features among women undergoing health examination at the National Cancer Institute, Thailand.
    Laowahutanont P; Karalak A; Wongsena M; Loonprom K; Pukcharoen P; Jamsri P; Sangrajrang S
    Asian Pac J Cancer Prev; 2014; 15(14):5879-82. PubMed ID: 25081717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.